Hsa-miR-223在人类围着床窗期子宫 内膜的表达及调控机制 学位申请人:黄凯 学科专业:妇产科学 指导教师:**旺教授 答辩日期: 2013年4月 ADissertationSubmittedinPartialFulfillmentofthe RequirementsfortheDegreeof Masterofmedicine TheExpressionandRegulationMechanismof ...
(2)高糖刺激能够导致HRGECs和HUVECs中hsa-miR-223-3p的下调以及IL6ST表达的上调,并激活下游STAT3和ERK1/2通路.(3)高糖刺激能导致HUVECs发生多种改变,包括形态和迁移速率改变,增殖速率下降,hsa-miR-223-3p可能为引发血管炎症反应的起始因素之一.(4)上调hsa-miR-223-3p在HUVECs中的表达,能够抑制IL6ST下游激活...
MicroRNA-223调控胚胎着床的机制研究 第一部分miR-223调控子宫内膜上皮细胞IGF-1R的表达 目的:构建miR-223过表达慢病毒载体,通过转染RL95-2上皮细胞系明确miR-223在子宫内膜上皮细胞中的靶基因. 方法:利用... 黄凯 - 《华...
Hsa-miR-155-3p和hsa-miR-155-5p作为系统性硬化症生物标志物及调控生物学行为的研究 目的:探讨hsa-miR-155-3p和hsa-miR-155-5p作为系统性硬化症(systemic sclerosis,SSc)生物标志物及调控生物学行为的研究.方法:选取10例SSc患者和10例健康对照者作为研... 王宝玥,孙晓林,王永福 - 《海南医学院学报》 被引量...
Thus, plasma hsa- miR-30e-5p, hsa- miR-92a-3p, and hsa- miR-223-3p may be promising novel biomarkers in the diagnosis and clinical manifestation of SLE.doi:10.1111/tan.12874B.-S.DepartmentKimDepartmentJ.-Y.DepartmentJungDepartmentJ.-Y....
The hsa-miR-30e-5p, hsa-miR-92a-3p, and hsa-miR-223-3p were significantly up-regulated in plasma of SLE patients ( P = 0.048, P = 0.039, and P = 0.046, respectively). Especially, the hsa-miR-223-3p was significantly associated with oral ulcer ( PB.‐S. Kim...
Kim BS, Jung JY, Jeon JY, Kim HA, Suh CH. Circulating hsa-miR-30e-5p, hsa- miR-92a-3p, and hsa-miR-223-3p may be novel biomarkers in systemic lupus erythematosus. HLA. 2016;88:187-93.Kim BS, Jung JY, Jeon JY, et al. Circulating hsa-miR-30e-Sp, hsa-miR-92a-3p, and hsa...
Using a nested case–control study within the European Prospective Investigation into Cancer and Nutrition (EPIC), the predictive values of five promising human miRNAs ( hsa‐miR‐16‐5p , hsa‐miR‐29a‐3p , hsa‐miR‐150‐5p , hsa‐miR‐155‐5p and hsa‐miR‐223‐3p ), identified in ...
通过唾液中hsa-miR-223-5p诊断高原头痛病的试剂盒本发明公开了一种通过唾液中hsamiR2235p诊断高原头痛病的试剂盒,涉及分子生物检测技术领域,所述试剂盒包含检测hsamiR2235p的试剂,可以对受测人进入高原后的血浆或唾液样本进行检测,被检测样本获取具有无创性,便捷性等特点,适合在平原人进入高原后进行大规模高原头痛病...
Therefore, plasma hsa-miR-223-3p is a novel biomarker for the severity in Different Stages of DKD in China.doi:10.2337/DB18-512-PJunyi HeRong LiLan LiYanan WuQiuping YangLihua ZhangAmerican Diabetes AssociationDiabetes